Featured
Fintech scandal: Exporo kicks out Upvest and switches to Tangany
What is a coup for Tangany could become a problem for Upvest. The Berlin-based fintech company says it manages $182 million (€150 million) in blockchain wallets. However, that is also exactly the amount at stake for Exporo, according to circles close to the company. So does Upvest not yet have any active customers in the custody business other than Exporo? This is contradicted in Berlin.
Real estate swarm financier Exporo is changing its service provider for the custody and trading of so-called tokens. This emerges from a customer letter sent on Friday evening. According to circles close to the company, an investment volume of around $182 million (€150 million) is affected. The letter, which is available to “Finanz-Szene” and “Finance Forward,” literally states: “We are changing the service provider that provides the wallets for token custody from Upvest to Tangany in the future.”
Read more on the subject and find the most important finance news with our companion app, Born2Invest.
Exporo had started tokenizing investment in real estate and real estate receivables in the summer of 2019
On this basis, the company issues digital securities that are stored in the Ethereum blockchain and traded there. The Berlin-based fintech company Upvest acted as a partner from the start. Tokenization should save costs compared to the traditional issuance, administration, and trading of securities or bonds. However, Exporo’s customer letter can now be understood as if the Ethereum blockchain itself had become a cost driver – and as if that was the reason for the switch to Tangany.
The letter uncompromisingly asks customers to actively agree to the switch to Tangany (an Upvest rival based in Munich). “Switching providers is not optional. If you do not agree to the switch, you will no longer be able to make corresponding investments on Exporo.de.” And further, “If you do not agree (…) you have to assume that Upvest will terminate your wallet, which would require you to provide a wallet yourself to store your tokens.”
What is a coup for Tangany could become a problem for Upvest. The Berlin-based fintech says it manages $182 million (€150 million) in blockchain wallets. However, that is also exactly the amount at stake for Exporo, according to circles close to the company. So does Upvest not yet have any active customers in the custody business other than Exporo? This is contradicted in Berlin. The volume placed via Exporo amounts to only 110 million euros. Of course, that would still be three-quarters of the assets in custody.
Now the custody of the assets is considered as low-margin business is (the speech is here of 0.08% per year). Consequently, Upvest founder Martin Kassing was emphatically relaxed when asked: “Financially, the step does not affect Upvest,” he said, without going into details. One continues to cooperate with Exporo. And: “We are in talks with potential customers who are much larger. Some of them have AuM sums of more than one billion euros.”
Tangany in turn explained on inquiry, including the new addition of Exporo customers the administered volume amounts to then $485 million (€400 million). The securities will continue to be held in custody via the Ethereum blockchain, while a separate private blockchain will be used for settlement.
__
(Featured image by TheDigitalArtist via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in finanz-szene.de, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Quirónsalud and Roche Farma Sign an Agreement to Promote Healthcare Innovation and Research
-
Business6 days ago
TopRanked.io Weekly Affiliate Digest: What’s Hot in Affiliate Marketing [1xBet Partner Program Review]
-
Biotech1 week ago
Novo Nordisk: Ozempic Gets Positive Evaluation for Kidney Treatment
-
Crypto7 days ago
Blackrock Just Launched the RWA Tokenization Snowball. Here’s How to Profit With SurancePlus [NASDAQ: OXBR]